{
  "@context": "aku-v2",
  "@type": "clinical-procedure",
  "@id": "vascular:procedure:bypass:fem-pop-above",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-07T01:00:00.000Z",
    "updated": "2026-01-07T01:00:00.000Z",
    "contributors": ["vascular-surgery-agent"],
    "confidence": 0.95,
    "status": "validated"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/procedures/bypass",
    "type": "clinical-procedure",
    "difficulty": "advanced",
    "importance": "high"
  },
  "content": {
    "identifier": "PROC-010",
    "title": "Femoropopliteal Bypass (Above-Knee)",
    "definition": "Surgical bypass from common femoral artery to above-knee popliteal artery for superficial femoral artery occlusive disease.",
    "concepts": [
      {
        "concept_id": "indications",
        "term": "Indications",
        "definition": "Clinical scenarios warranting above-knee femoropopliteal bypass.",
        "clinical_features": {
          "primary": ["Lifestyle-limiting claudication refractory to exercise therapy and medical management", "Critical limb ischemia (rest pain, tissue loss)"],
          "lesion_characteristics": ["TASC C/D lesions", "Long-segment SFA occlusion", "Failed endovascular intervention"],
          "anatomy": "Patent above-knee popliteal artery with good runoff"
        }
      },
      {
        "concept_id": "conduit-selection",
        "term": "Conduit Selection",
        "definition": "Choice of bypass conduit for femoropopliteal reconstruction.",
        "clinical_features": {
          "great_saphenous_vein": {
            "patency": "5-year primary patency 70-80%",
            "preparation": ["Reversed", "Non-reversed with valve lysis", "In-situ"],
            "diameter": "Minimum 3mm, ideally 4-5mm"
          },
          "prosthetic": {
            "materials": ["PTFE", "Dacron", "Heparin-bonded PTFE"],
            "patency": "5-year primary patency 40-50% above-knee",
            "indications": "Inadequate vein, need for rapid revascularization"
          }
        }
      },
      {
        "concept_id": "technique",
        "term": "Surgical Technique",
        "definition": "Key technical aspects of femoropopliteal bypass construction.",
        "clinical_features": {
          "inflow": "Common femoral artery via groin incision, endarterectomy if needed",
          "outflow": "Above-knee popliteal via medial thigh incision",
          "anastomosis": "End-to-side, 6-0 or 7-0 polypropylene",
          "tunnel": "Anatomic subsartorial vs superficial route"
        }
      },
      {
        "concept_id": "outcomes",
        "term": "Outcomes",
        "definition": "Expected outcomes following above-knee femoropopliteal bypass.",
        "clinical_features": {
          "patency_vein": "5-year primary patency 75-80%, secondary 85%",
          "patency_prosthetic": "5-year primary patency 50-60%, secondary 65-70%",
          "limb_salvage": "85-90% at 5 years for CLI",
          "mortality": "1-3% perioperative"
        }
      }
    ],
    "clinical_features": {
      "surveillance": "Duplex at 1, 3, 6, 12 months then annually",
      "anticoagulation": "Controversial - aspirin minimum, some add anticoagulation for prosthetic"
    },
    "diagnostic_criteria": {
      "graft_stenosis": "PSV ratio >3.5 or absolute PSV >300 cm/s"
    }
  },
  "relationships": [
    {"type": "alternative_to", "target": "vascular:procedure:endovascular:sfa-intervention"},
    {"type": "requires", "target": "vascular:anatomy:sfa"},
    {"type": "conduit_from", "target": "vascular:anatomy:gsv"}
  ],
  "provenance": {
    "sources": [
      {"reference": "Conte MS et al. J Vasc Surg. 2019;69:3S-125S", "type": "guideline"},
      {"reference": "BASIL Study. Lancet. 2005;366:1925-1934", "type": "primary"}
    ],
    "extraction_method": "expert-review"
  }
}
